Documentos relacionados

1. Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection.
2. A glycolytic metabolite bypasses "two-hit" tumor suppression by BRCA2.
3. PhenoDriver: interpretable framework for studying personalized phenotype-associated driver genes in breast cancer.
4. Homologous recombination deficiency reflects the heterogeneity and monitoring treatment response for patients with breast cancer.
5. Aldehydes Pose a Threat to BRCA2 Mutation Carriers.
6. Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing.
7. De novo individualized disease modules reveal the synthetic penetrance of genes and inform personalized treatment regimens.
8. Factors that influence the management recommendations breast surgeons provide to women with pathogenic variants in moderate penetrance breast cancer susceptibility genes.
9. Cooperative driver pathways discovery by multiplex network embedding.
10. Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia.